Quote:
Originally Posted by Trapper John
Doc, I am helping a friend who is in the process of acquiring a nano-technology that can be applied to antibiotic formulations. The idea is to enhance bioavailability (lower dosages) in PO formulations. Also reduce adverse event occurrence (reduced toxicity). The initial target market will be military applications.
The preliminary data is very encouraging.
If you were to select any of the existing antibiotics (older ones too) that could be re-purposed, what would those be and why?
Any of you active 18Ds please chime in too.
Thanks,
JDT
Sine Pari
|
Is the technology for oral or IV formulations?
__________________
"The dignity of man is not shattered in a single blow, but slowly softened, bent, and eventually neutered. Men are seldom forced to act, but are constantly restrained from acting. Such power does not destroy outright, but prevents genuine existence. It does not tyrannize immediately, but it dampens, weakens, and ultimately suffocates, until the entire population is reduced to nothing better than a flock of timid, uninspired animals, of which the government is shepherd." - Alexis de Tocqueville
|